Correction: Individual patient data to allow a more elaborated comparison of trial results with real-world outcomes from second-line immunotherapy in NSCLC (BMC Medical Research Methodology, (2023), 23, 1, (1), 10.1186/s12874-022-01760-0)

Autor: Ismail, R K, Schramel, F M N H, van Dartel, M, Pasmooij, A M G, der Welle, C M Cramer-van, Hilarius, D L, de Boer, A, Wouters, M W J M, van de Garde, E M W, Afd Pharmacoepi & Clinical Pharmacology, Pharmacoepidemiology and Clinical Pharmacology
Jazyk: angličtina
Rok vydání: 2023
Zdroj: BMC Medical Research Methodology, 23(1). BioMed Central
ISSN: 1471-2288
Popis: Following publication of the original article [1], the authors requested to correct the word “first-line” to “second-line” in the article title. The original article has been updated.
Databáze: OpenAIRE